- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Results
12
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SANN | CHF 11.44 | 18.9% | 13.9% | CHF 138.5m | CHF 32.00 | PE2.2x | E35.4% | n/a | ||
NWRN | CHF 8.49 | 3.5% | 91.6% | CHF 165.2m | CHF 14.39 | PS25.3x | E56.5% | n/a | ||
BSLN | CHF 41.15 | -1.0% | 20.0% | CHF 498.8m | CHF 77.25 | PS3.3x | E22.0% | 0% | ||
SDZ | CHF 37.06 | 0% | 34.4% | CHF 16.3b | CHF 43.50 | PS1.8x | E34.9% | 1.2% | ||
SKAN | CHF 76.40 | 7.2% | -6.0% | CHF 1.7b | CHF 90.67 | PE53.3x | E18.7% | 0.5% | ||
GALD | CHF 98.35 | 3.6% | n/a | CHF 23.4b | CHF 99.88 | PS6x | E44.6% | n/a | ||
COPN | CHF 61.20 | 2.5% | 18.1% | CHF 982.0m | CHF 97.30 | PE15.1x | E17.2% | 3.1% | ||
LONN | CHF 532.40 | -1.7% | 50.6% | CHF 38.5b | CHF 636.90 | PE67.1x | E23.4% | 0.8% | ||
PPGN | CHF 28.60 | -1.4% | 65.9% | CHF 943.3m | CHF 36.25 | PS3.1x | E64.2% | 0% | ||
TECN | CHF 203.00 | -1.8% | -41.1% | CHF 2.6b | CHF 284.86 | PE25.7x | E14.8% | 1.5% | ||
BANB | CHF 57.80 | -9.8% | -10.5% | CHF 4.3b | CHF 83.57 | PE38.2x | E17.9% | 1.4% | ||
SFZN | CHF 979.00 | -0.1% | 15.4% | CHF 4.2b | CHF 1,187.67 | PE32.6x | E13.7% | 0.4% |
Page 1 of 1